about
Standardization of cytokine flow cytometry assaysNeoantigen-based cancer immunotherapyNovel technologies and emerging biomarkers for personalized cancer immunotherapyImproved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsMART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trialHIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells.Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosisDNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.Cytomegalovirus (CMV)-specific cellular immune responses.Positive and negative regulation of cellular immune responses in physiologic conditions and diseasesSkewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotypeThe number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexesHigh-throughput monitoring of human tumor-specific T-cell responses with large peptide pools.Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responsesAn HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.Functional signatures of protective antiviral T-cell immunity in human virus infections.HIV-1-specific immune response.Effect of Schistosoma mansoni Infection on Innate and HIV-1-Specific T-Cell Immune Responses in HIV-1-Infected Ugandan Fisher Folk.Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposureRole of HIV-1-specific CD4 T cells.Clinical studies of experimental vaccines.Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.Functional avidity: a measure to predict the efficacy of effector T cells?Personalized approaches to active immunotherapy in cancer.Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.Immune monitoring technology primer: flow and mass cytometry.CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression.Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load.Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease.NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.[Specific interferon-gamma assays: a modern tool for tuberculosis diagnosis]Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure.Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C.EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.
P50
Q24811983-53C97C7F-8FCD-475D-AE0C-E90DD786EF52Q26738693-A7D4ADAF-65C1-4DAC-AAC9-3C9460342092Q26770780-1C410626-B6CD-446F-AD69-D2BE7701ED7EQ28742751-1D28687F-2ADB-4460-B843-A2D5C04E48C0Q33614005-3C0FE0F2-1A6C-40FB-A9F9-3EB7D0ED4D1DQ33772204-26A74084-4BC4-445C-BA1B-8CFC96663493Q34247289-EAE6431F-E9D8-4955-AC64-3A87CA52E5F8Q34819446-FFAFCCEE-1AFC-404C-A115-C3CCC055784BQ34945981-750D9139-B7B0-4097-97E7-526C99ED2558Q35382338-00EB6701-54BC-475D-ACF8-24D0215C2FA5Q35488175-799B94EF-9B9D-4B80-A191-FA2E47649B09Q35789364-BD250AAB-E9DD-42A2-A350-C57767F79EFFQ35883043-8CBAD950-1F7B-432D-8E5F-D674C3B38D49Q36022184-F3F92F9F-B08C-43D4-901C-51BC118236D2Q36023055-92E66CC8-642A-4BF7-A8FE-9F8DDEEF43E0Q36110300-D1C8C1A4-8916-418B-90EE-7F60DF450EC8Q36229406-17F6E504-869B-41AF-9C2F-97A6DFB9AD20Q36446900-729EA19E-4707-4CD4-92A6-E2F6953777F6Q36452614-2776CA3F-5CF6-4179-A8DF-021D9EFC1371Q36529008-1F2DBC79-4E98-4203-B73E-B2562C67AFEDQ37034594-95C9DE87-2CCC-452D-A722-90DD4BAEF47AQ37062188-0CC074D4-5896-44AD-8E0C-2FAE6D3DBB53Q37127942-1FD057FA-A823-4B61-9584-0623FCFD7EDEQ37446741-D66DCF17-F010-4B95-9343-8D6339EEED15Q37446948-F6E6339B-35B9-42D8-879D-0F84FFDDBADFQ38002002-0B613B41-CB71-4F6F-9786-E48FB0C01C4AQ38066211-27F574AA-C0BB-48F6-9A93-0C1CE1788860Q38560498-62A65860-8223-4C6C-9BED-D6B5AE2DCAAEQ39992443-BB0D8F99-3AB2-46D1-866B-F9889C18FF39Q40994711-74BDD51F-5CB4-43CB-8EFB-101BD99D3FE5Q41726535-AD46B5BD-DAB3-4E3D-81F9-C0C7C8640CBEQ43779427-1EE4B7EA-1630-4246-95A1-8CC907CB9044Q44318621-0F5D0F89-1D5C-453D-87C5-617BECCECE05Q44766920-769BA29B-900E-4529-94B9-C3A9717FEC9FQ45169113-5CC559AE-DC10-4243-B2BA-3E8FD721149EQ45366709-11CF0709-319D-4559-933F-CEA01A2B2C73Q45409477-9F079BE9-562B-4C79-9D4B-8CF49593B52EQ45721932-B0FDCFDD-FCD0-4186-8574-E73CE59F78FDQ45908916-DC511C6C-EF6B-4000-849D-C03ADF540674Q46576663-83D3C6BA-CDDE-4152-AA2B-D5EF13737A65
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alexandre Harari
@ast
Alexandre Harari
@en
Alexandre Harari
@es
Alexandre Harari
@nl
type
label
Alexandre Harari
@ast
Alexandre Harari
@en
Alexandre Harari
@es
Alexandre Harari
@nl
prefLabel
Alexandre Harari
@ast
Alexandre Harari
@en
Alexandre Harari
@es
Alexandre Harari
@nl
P106
P21
P31
P496
0000-0002-1055-2090